US Stock MarketDetailed Quotes
EDSA Edesa Biotech
- 2.1100
- -0.0900-4.09%
Close Nov 21 16:00 ET
6.85MMarket Cap-959P/E (TTM)
2.1611High2.0500Low13.55KVolume2.1000Open2.2000Pre Close28.21KTurnover0.54%Turnover RatioLossP/E (Static)3.25MShares6.460052wk High2.39P/B5.31MFloat Cap2.050052wk Low--Dividend TTM2.52MShs Float461.1600Historical High--Div YieldTTM5.05%Amplitude2.0500Historical Low2.0820Avg Price1Lot Size
About Edesa Biotech Company
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
Company Profile
SymbolEDSA
Company NameEdesa Biotech
Listing DateNov 5, 2015
Founded2007
CEODr. Pardeep Nijhawan, F.R.C.P.C,M.D.
MarketNASDAQ
Employees16
Fiscal Year Ends09-30
Address100 Spy Court
CityMarkham
ProvinceOntario
CountryCanada
Zip CodeL3R 5H6
Phone1-289-800-9600
Websitehttp://www.edesabiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Pardeep Nijhawan, F.R.C.P.C,M.D.
- Director, Chief Executive Officer and Corporate Secretary
- 549.56K
- Stephen L. Lemieux
- Chief Financial Officer and Principal Accounting Officer
- 155.94K
- Dr. Michael Brooks, M.B.A.,PhD
- President
- 488.76K
- Carlo Sistilli, C.M.A.,C.P.A.
- Chairman of the Board
- 67.83K
- Joan Chypyha
- Independent Director
- 30.81K
- Sean MacDonald
- Independent Director
- 68.01K
- Charles V. Olson, D.Sc.
- Independent Director
- 28.13K
- Frank R. Oakes
- Independent Director
- 56.37K
- Patrick Marshall
- Independent Director
- 29.20K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data